CSGP vs CTOR · P/E 484, rev $2.74B vs $105.2M cap
CoStar Group Inc (CSGP) versus Citius Oncology, Inc. (CTOR) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
CTOR does not have a complete income-statement cache yet.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. CTOR currently screens at market cap $105.2M.
Not investment advice. Open the CSGP and CTOR stock pages for the full models.
Not investment advice.